The 6th Int'l Conference on Cancer Therapy and Translational Medicine(CTTM 2026)

IN_PERSON

Event Link

Ready to Wow at the Conference?

Your paper deserves more than just slides.

showcase your research with researchbunny pages

Turn it into a multilingual audio brief, smart chat, and a sleek summary, all in one ResearchBunny Page.

Let your work speak for itself, literally.

Click here for demo

The 6th Int'l Conference on Cancer Therapy and Translational Medicine(CTTM 2026)

Kunming, China

WORKSHOP

Registration

To join or learn more about the event, please visit the organizer's website.

Event Details

Date: November 27-29, 2026
Venue: Kunming, China
Website: https://www.academicx.org/CTTM/2026/
Email: contact11@academicx.org (wsaugust@126.com)
Index: CNKI

🌏 Conference Background

The 6th International Conference on Cancer Therapy and Translational Medicine (CTTM 2026) will be held from November 27th to 29th, 2026, in the picturesque city of Kunming, China. This premier academic event will explore a wide range of critical topics in cancer research and translational medicine, including:

Cancer and Biopsies
Cancer Diagnostic Tools, Technologies, and Procedures
Clinical Cancer Research
Clinical Management of Cancer
Translational Medicine
Viral Oncology

Other significant areas of study will also be addressed.

📝 Call For Papers

CTTM 2026 invites researchers to submit their papers and participate in academic discussions. The conference is soliciting cutting-edge research in the following areas:

Topics of Interest:

Immunotherapy
Targeted Therapy
Gene Therapy in Cancer
Precision Medicine
Nanotechnology in Cancer Therapy
Combination Therapies
Radiation Oncology Innovations
Epigenetic Therapies
Oncolytic Virus Therapy
Liquid Biopsy Technology
Metabolic Targeting in Cancer
Artificial Intelligence in Cancer Treatment
Cancer Stem Cells (CSCs)
Autophagy and Cancer
Anti-Angiogenic Therapy
Microbiome and Cancer Therapy
Theranostics
Photodynamic Therapy (PDT)
Overcoming Drug Resistance
Exosome and Extracellular Vesicle Therapy
CAR-NK and TCR Therapies
Liquid Cancer Treatments (Leukemia and Lymphomas)
Regional Therapy Approaches
Novel Chemotherapeutics
Tumor Microenvironment Targeting
Genome Editing and CRISPR Technology
Biomarker Discovery and Validation
Clinical Trials in Translational Medicine
Regenerative Medicine and Stem Cell Therapy
Drug Repurposing
Microbiome Research
Translational Oncology
Organoids and Lab-on-Chip Models
Liquid Biopsy
Translational Neuroscience
Vaccine Development
Targeting Rare Diseases
Epigenetics and Disease Therapy
Translational Research in Infectious Diseases
Nanomedicine
Translational Cardiovascular Medicine
Health Disparities in Translational Medicine
Pharmacogenomics
Translational Psychiatry

📍 Attendance Methods

1. Regular Attendance (No Submission Required)

Participants are welcome to attend the conference without submitting a full paper or abstract.

2. Abstract Submission

Submit an abstract for oral presentation or poster presentation.
Includes Regular Attendance + Abstract + Presentation.

3. Full Paper Submission

Submit a full paper for publication and presentation.
Includes Regular Attendance + Paper Publication + Presentation.
One author will be invited to deliver an oral presentation, and the paper will be published in a peer-reviewed open-access journal.